An Evaluation of the Safety and Efficacy of Moxifloxacin Ophthalmic Solution 0.5% Versus Ofloxacin Ophthalmic Solution 0.3% in the Treatment of Bacterial Conjunctivitis in Chinese Patients

Inclusion Criteria:

• Be at least one year of age (of either sex and of Chinese race).

• Diagnosis of bacterial conjunctivitis based on clinical observation.

  • Rating ≥1 for bulbar conjunctival injection and ≥1 for conjunctival discharge/exudate in at least one eye (the same eye) and;
  • Matting in the affected eye(s).
• Understand and sign the approved Informed Consent. Legally authorized representative can provide informed consent for patients under 18 years old and/or patients incapable of understanding the Informed Consent.
• Willing to complete all required study procedures and visits.
• Other protocol-defined inclusion criteria may apply.

Exclusion Criteria:

• Pregnant or lactating women, women who have a positive urine pregnancy test, or women who are planning a pregnancy.
• Only one sighted eye or vision not correctable to 0.6 logMAR or better in either eye. Visual acuity measurement for children less than 5 years of age is to be conducted at the discretion of the investigator. If visual acuity is not measured, the child must be able to fix and follow.
• Participation in any other investigational clinical study within the previous 30 days.
• Planned contact lens wear during the course of the study.
• Presence of signs and symptoms of bacterial conjunctivitis for longer than 4 days prior to Screening (Day 1).
• Suspected fungal, viral, or Acanthamoeba infection based on clinical observation.
• Presence of active inflammation and/or active structural change in the cornea, iris, or anterior chamber at Screening.
• Known or suspected allergy or hypersensitivity to any component of the study medications.
• Use of any topical ocular medications at time of entry into the study or during study participation.
• Other protocol-defined exclusion criteria may apply.